Abstract PO018: PAX8 represents a potential novel therapeutic target in copy number high uterine serous carcinomaSusan Read, Bing Zhang, Yongchao Dou et al.|Clinical Cancer Research|2021Cited by 0
Abstract 1317: The role of PAX8 in copy number-high uterine cancers: Inflammatory cytokine modulationLauren E. Karnolt, Matthew L. Anderson, Maja Okuka et al.|Cancer Research|2022Cited by 0